Plasma Cell Leukemia: An Overview
Journal: Haematology International Journal (HIJ) (Vol.5, No. 1)Publication Date: 2021-02-09
Abstract
Plasma cell leukaemia (PCL) is a rare haematological malignancy which is classified into primary (pPCL) and secondary PCL (sPCL). The rising incidence of sPCL is attributed to improved survival in multiple myeloma Kyle's criteria define pPCL as 20% or more plasma cells and at least 2×109 /L plasma cells in the peripheral blood but the International Myeloma Working Group (IMWG) suggests that either one is sufficient for a diagnosis of PCL [1].
Other Latest Articles
- Evan’s Syndrome - A Case Report
- Haematological Profile in COVID-19 Infection
- Long-Term Rather than Short-Term Survival Benefit in Mantle Cell Lymphoma Patients Treated With Intensive ChemoImmunotherapy and Hematopoietic Stem Cell Transplantation in Real World Experience
- Prevalence of ABO and RhD Antigen in District Nowshera an Experience in Blood Bank of Qazi Hussain Ahmed Medical Complex Nowshera
- COVID-19-Driven Immunoparalysis and Cytokine Storm: Can Hematologists Contribute to the Battle?
Last modified: 2022-09-12 18:33:48